Association Between Micronutrients and Cognitive Performance Among Adolescents and Young Adults Living With Sickle Cell Disease in Kumasi, Ghana: A Cross-Sectional Study [0.03%]
加纳库马西市镰状细胞病青少年和年轻成人微量元素摄入与认知表现横断面研究
Albert Dennis Kegya,Mary Amoako,Vivian Paintsil et al.
Albert Dennis Kegya et al.
Aim: Cognitive deficits are commonly reported in patients with sickle cell disease (SCD). Dietary micronutrient intake is a potential modifiable risk factor whose relationship with cognition in SCD patients remains poorly...
European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up Dosing [0.03%]
欧洲推荐:将治疗多发性骨髓瘤患者的护理从学术医院转到社区中心以及日间门诊给药的建议——这些患者使用B细胞成熟抗原双特异性抗体治疗
María-Victoria Mateos,Elena Zamagni,Massimo Gentile et al.
María-Victoria Mateos et al.
Introduction: Safe outpatient delivery of B-cell maturation antigen-targeting bispecific antibodies (BCMA-BsAbs) in multiple myeloma (MM) is challenging, particularly during step-up dosing (SUD). Standardized guidance for...
Reticulated Platelets and an Optimal Model for Differentiating Thrombocytopenia Etiologies [0.03%]
网状血小板与区分血小板减少病因的优化模型
Tung Thanh Tran,Quyen Ngoc Truong,Hong Phuoc Mac et al.
Tung Thanh Tran et al.
Objectives: This study aimed to investigate the clinical value of reticulated platelets (RtcPLT) percentage derived from an automated hematology analyzer in differentiating thrombocytopenia due to peripheral etiology from...
Circulating CD117+/CD34+/CD45dim Myeloblasts as Biomarkers of Disease Activity in Primary Myelofibrosis-A Pilot Study [0.03%]
C-D34、C-D45和C-D117联合检测作为原发性骨髓纤维化病活动性的生物标志物的初步研究
Malak Tamer Abdelmaksoud,Zsuzsanna Hevessy,Judit Bedekovics et al.
Malak Tamer Abdelmaksoud et al.
Introduction: Clinical benefit measures and surrogates for leukaemic transformation or overall survival are scarce in MF. Circulating myeloblast (CMB) counts have the biological plausibility to indicate disease evolution,...
Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial [0.03%]
allo-HSCT受者接受体外光敏疗法以预防移植物抗宿主病的类维甲酸和类胡萝卜素血浆水平变化:一项随机试验的分析结果
Per Ole Iversen,Maryan Mohamed Ali,Nasser E Bastani et al.
Per Ole Iversen et al.
Introduction: Whether retinoids and carotenoids impact on graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (ASCT) is unknown. ...
Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts [0.03%]
阿扎胞苷联合丽沙富氯克塞治疗复发/难治性急性髓系白血病和增生型骨髓增生异常综合征的疗效及安全性
Shan Meng,Wanhong Zhao,Hui Zhang et al.
Shan Meng et al.
Objective: To retrospectively analyze the early efficacy and safety of azacitidine plus lisaftoclax in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome with increased blasts (MDS-IB), providing a re...
Peripheral T-Cell Lymphomas in Southern Taiwan: Epidemiology, Treatment Patterns, and Long-Term Outcomes [0.03%]
台湾南部外周T细胞淋巴瘤的流行病学、治疗模式及长期结局
Bo-Yu Huang,Li-Chang Chang,Sheng-Yen Hsiao et al.
Bo-Yu Huang et al.
Peripheral T-cell lymphomas (PTCLs) are heterogeneous neoplasms with poor prognosis and marked geographic variation. Data from Taiwan remain limited. We conducted a 15-year retrospective cohort study of 249 patients diagnosed with PTCL at t...
Jochen Pfeifer,Laura Ziegler,Luise S Porges et al.
Jochen Pfeifer et al.
Putative Clonal Evolution in a PHF6-Mutant T/NK-Cell Lymphoproliferative Disorder With Selective Loss of a STAT5B-Mutant Subclone [0.03%]
PHF6突变T/NK细胞淋巴增生性疾患中STAT5B突变亚克隆丢失的假定克隆进化现象
Mark Anthony Turingan,Cuihong Wei,Nihad Almokhtar et al.
Mark Anthony Turingan et al.
Treatment Outcomes and Overall Survival of Patients With B-Cell Prolymphocytic Leukemia [0.03%]
B细胞prolymphocytic白血病的治疗结局和总生存期
Daniel A Ermann,Victoria A Vardell,Lindsey Fitzgerald et al.
Daniel A Ermann et al.
Introduction: B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive leukemic B-cell malignancy historically associated with poor outcomes and recently reclassified in the WHO Fifth Edition but retained as a distinc...